
    
      -  Participants will be seen by the study physician every four weeks and have a short
           physical examination, blood tests and be asked to provide information about their
           condition. Every three months they will undergo a bone scan. If the CT scan that was
           obtained before the participant started the study shows evidence of cancer, they will be
           asked to repeat this test every three months.

        -  Ketaconazole will be taken orally three times a day on an empty stomach. Hydrocortisone
           will be taken orally in the morning and at night. Dutasteride will be taken orally once
           a day.

        -  Participants may remain on study drug until there is evidence of disease progression.
    
  